NCT00923182
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Chiba, Japan
- Tsukuba, Ibaraki, Japan
- Sendai, Miyagi, Japan
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,990 public trials
1,836 recruiting studies
Lymphatic Diseases trial results
NCT00087425
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
- Locations
-
- NIH - Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
NCT00045500
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +40 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- NCI - Center for Cancer Research Bethesda, Maryland, United States
- Frederick Cancer Research and Development Center Frederick, Maryland, United States
NCT00991133
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- The Children's Hospital Aurora, Colorado, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Children's Memorial Hospital Chicago, Illinois, United States
NCT00020462
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Medicine Branch Bethesda, Maryland, United States
NCT00060021
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
NCT00007956
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +27 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- Center for Cancer Research Bethesda, Maryland, United States
Completed
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
NCT00085150
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +31 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- Doernbecher Children's Hospital at Oregon Health & Science University Portland, Oregon, United States
Completed
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00003993
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- National Institute on Aging - Baltimore Baltimore, Maryland, United States
NCT00002765
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Laboratory of Molecular Biology Bethesda, Maryland, United States
- Medicine Branch Bethesda, Maryland, United States